October 2018 - Page 5 of 7

ThursdayOct 11, 2018 9:00 am

Fresh Acquisitions Help Companies Profit from Growth in the Cannabis Sector

CBDWire Editorial Coverage: A wave of acquisitions is sweeping the cannabis sector, as increasing legalization draws the attention of big business. Large and mid-tier cannabis companies are absorbing their smaller competitors. Tobacco and alcohol companies are moving in as a natural extension of their current ranges. This is supported by growth not just among cannabis growers but also for businesses supporting them. Cultivation supplies company Sugarmade, Inc. (OTC: SGMD) (SGMD Profile) has recently announced the acquisition of hydroponic product companies that could more than double its revenue. Tilray, Inc. (NASDAQ: TLRY) is fueling expansion through an initial public offering as it…

ThursdayOct 11, 2018 9:00 am

CBD Exploding into Mainstream Wellness Products

CBDWire Editorial Coverage: Bolstered by millennia of anecdotal evidence and ever-mounting scientific validation, cannabidiol (CBD) is rapidly being integrated into myriad mainstream consumer wellness products around the globe. Global cannabis market expected to quadruple to over $63 billion by 2024 CBD oil market to grow at CAGR of 39.19 percent through 2021 CBD products exploding into a wide variety of product lines Diversified, sales-driven companies expected to outpace standard growth curve Humans have used hemp, a variety of Cannabis sativa and a primary source of CBD, for more than 10,000 years in food, textiles and medicine. The world is again…

WednesdayOct 10, 2018 12:48 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Infuses Cannabis Industry, Delivers Results with Innovative Drug Delivery Platform

Global legal cannabis market projected to surpass $146 billion by end of 2025 Cannabinoid-infused edibles, concentrates represent fastest-growing segment of industry Lexaria’s patented technology improves bio-absorption and bioavailability of active ingredients while masking unpleasant taste Lucrative licensing business model includes agreements to enhance cannabinoid (CBD) delivery before year-end 2018 Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and its proprietary technology found in the company’s drug delivery platform DehydraTECH has application for several subsets of the cannabis industry and other pharmacological verticals. As a technology proven to deliver increased intestinal absorption rates and higher bioavailability for a number of bioactive compounds,…

WednesdayOct 10, 2018 12:01 pm

ChineseInvestors.com, Inc.’s (CIIX) CBD Biotechnology Co. Ltd. Sets December Launch for CBD Hemp-Infused Rice Wine, Sees it as ‘Sales Driver’

CIIX’s wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (CBD Biotech), will debut new private label wine at peak period for liquor sales in China Company recorded sales of $2.35 million for FY2018, up 41 percent from $1.66 million the prior year Summer Yun, CEO of CBD Biotech, anticipates greater volume during the top sales season for liquor ChineseInvestors.com, Inc.’s (OTCQB: CIIX) CBD Biotech, a wholly owned foreign enterprise, plans to debut a CBD hemp-infused rice wine in December, during China’s peak holiday/festival season that includes Christmas, New Year’s, and Spring Festival (http://cnw.fm/cq9AQ). In a news release, Warren Wang, CEO of…

WednesdayOct 10, 2018 11:19 am

DEA Decision to Remove Some Cannabidiol from Most Restrictive Class of Controlled Substances May Have Far-Reaching Impact on the CBD Market

The U.S. Drug Enforcement Administration (DEA) ruling enables physicians to prescribe Epidiolex, a non-synthetic cannabis-derived medicine from United Kingdom-grown cannabis Cannabis entrepreneurs applaud the decision, even though it only applies to that specific drug; DEA decision requires approval of medications by the U.S. Food & Drug Administration (FDA) Several other CBD medications are in the pipeline for consideration by the FDA; move is seen as legitimizing the industry and changing it to traditional distribution of prescription-to-drug store The DEA decision to approve the first non-synthetic CBD-derived drug, Epidiolex, and remove it from the agency’s most restrictive class of controlled substances…

WednesdayOct 10, 2018 10:54 am

Green Hygienics Holdings Inc. (GRYN) Acquires Canna Brands Portfolio

The three online platforms provide a strategic step forward in advancing the company’s business model by creating tools to introduce the existing portfolio brands into vertical markets Again the company is setting itself apart by further demonstrating a unique business approach toward advancing operations and creating value in the sector The acquisition portfolio has the potential to generate substantial revenues on its own Full-scope premium cannabis company Green Hygienics Holdings Inc. (OTC: GRYN) recently announced that it has acquired the Canna Brands Portfolio. This acquisition centers on three core products: Cannagram, Myijuana and The CoursePro Academy. The full press release…

TuesdayOct 09, 2018 12:35 pm

SeeThruEquity Features Sugarmade, Inc. (SGMD) as Company Looks Forward to Passage of Hemp Bill

SeeThruEquity recommends a share price of $0.30 Bill would make hemp an ordinary agricultural product and no longer a controlled substance Hemp-derived cannabidiol market worth $591 million, expected to hit $22 billion in under five years With the U.S. Congress on the verge of making hemp an ordinary agricultural crop instead of a controlled substance, hydroponics supply company Sugarmade, Inc. (OTCQB: SGMD) has made comments on its recent venture into the hemp market (http://cnw.fm/S9kaJ). Sugarmade last month announced that it was investing $1 million in Hempistry, Inc., a company producing ultra-high cannabidiol hemp. Hempistry in July started work on cultivating hemp…

TuesdayOct 09, 2018 12:19 pm

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Signs Partnership with Lighthouse Genomics, Inc.

Technology partnership signed with Integral Genomics Inc. (dba Lighthouse Genomics Inc.) to support BLOCKStrain’s registry of genetic profiles of cannabis strains Valuable intellectual property rights of cannabis cultivators under attack from unscrupulous illegal growers, gray market Recent reschedule of first FDA-approved drug derived from cannabis paves the way for sales, underscores necessity of BLOCKStrain’s “Single Source of Trust” registry Legislation efforts growing in U.S. as Canada readies recreational cannabis sales throughout nation Global legal cannabis market projected to reach $146.4 billion by end of 2025 In a move crafted to support advancements in science and technology within the legal cannabis…

TuesdayOct 09, 2018 11:02 am

Cannabis Strategic Ventures, Inc. (NUGS) Aims to Clear Higher Hurdle in Reporting Standards

Completion of full audit for fiscal year ended March 31, 2018 Close of three-year audit required to become fully reporting company with SEC Plans afoot to uplist to a higher OTC Markets tier Cannabis Strategic Ventures, Inc. (OTC: NUGS) wants to be an open book. The company has announced the completion of a full audit for its fiscal year ended March 31, 2018. This marks the close of the three-year audit required as a condition of becoming a fully reporting company with the U.S. Securities & Exchange Commission (SEC). Cannabis Strategic Ventures will utilize the audit results to file future…

TuesdayOct 09, 2018 9:00 am

Public Acceptance Fuels Growth of CBD and Support Industries

CBDWire Editorial Coverage: Growing public acceptance of medical marijuana is having secondary effects on other industries. Products using cannabidiol (CBD) are increasingly popular in areas such as wellness and cosmetics. Hemp production is growing, with experimental projects improving cannabis cultivation techniques. Services needed to support these markets, such as payment systems, are growing. Marijuana Company of America, Inc. (OTC: MCOA) (MCOA Profile) is benefiting from this in many ways, having invested in hemp, CBD products, rentable cultivation space and payment systems. Tilray, Inc. (NASDAQ: TLRY) is producing CBD oils and has become one of the first companies to sell these…

News and publishing service for CBD related companies

Contact us: 303.498.7722

Month: October 2018